Tom Mirga

PhRMA and Arkansas Seek Faster Court Ruling on State’s Novel 340B Contract Pharmacy Law

In Federal, JudicialJanuary 21, 2022296 Views

PhRMA and the state of Arkansas have agreed on a plan that could lead the federal district court in Little Rock to rule sooner than now anticipated on the state’s law protecting 340B contract pharmacy arrangements.

The brand name drug industry and the state of Arkansas have agreed on a litigation plan that could lead to a quicker federal court decision than now anticipated on the state’s one-of-a-kind law protecting 340B contract pharmacy arrangements.

…

AHA Asks Congress to Attach 340B Hospital Protections to Must-Pass Spending Bill

In Federal, Legislative, Trade AssociationJanuary 21, 2022184 Views

Tom Mirga

The AHA asked congressional leaders yesterday to ensure that a must-pass spending bill next month protects hospitals from losing their 340B eligibility due to changes forced on them by the COVID-19 pandemic.

The American Hospital Association (AHA) yesterday asked U.S. House and Senate party leaders to ensure that a must-pass spending bill next month protects hospitals from losing their 340B eligibility due to changes in patient and payer mix caused by the

…

Three Drug Makers, Including Two with Contract Pharmacy Restrictions, Post 340B Refund Notices

In Federal, Pharma Industry, RegulatoryJanuary 21, 2022326 Views

Tom Mirga

Bristol Myers Squibb, Novo Nordisk, and Ipsen Biopharmaceuticals notified 340B covered entities this week about refunds for charges above 340B ceiling prices.

Three drug manufacturers—including two that have imposed conditions on 340B contract pharmacy—posted public notices this week to 340B covered entities about refunds for charges above 340B ceiling prices.

Please Login or Become a Paid Subscriber to

…

Democrats Weigh Passing Build Back Better Act—Possibly Including Drug Pricing Reforms—in “Chunks”

In Federal, LegislativeJanuary 21, 2022111 Views

Tom Mirga

New CBO findings on brand drug price increases “drive home the urgent need to pass robust drug pricing reforms," U.S. Senate Finance Committee Chair Ron Wyden (D-Ore.) said this week.

U.S. Senate Finance Committee Chair Ron Wyden (D-Ore.) said this week that new Congressional Budget Office (CBO) findings on brand drug price increases “drives home the urgent need to pass robust drug pricing reforms.”

Please Login

…

Groups and Individual Health Care Providers Grapple with BMS’s New 340B Contract Pharmacy Policy

In Pharma IndustryJanuary 19, 2022653 Views

Tom Mirga

Individual 340B covered entities are deciding how to respond to the multi-point 340B contract pharmacy policy that Bristol Myers Squibb (BMS) released last Friday.

Groups that represent 340B hospitals yesterday slammed the multi-point 340B contract pharmacy policy that Bristol Meyers Squibb (BMS) released last Friday.

Please Login or Become a Paid Subscriber to View this Content

…

With Judge in Astra 340B Case About to Get Promotion, What Will Happen to the Highly Anticipated Case?

In Federal, JudicialJanuary 19, 2022200 Views

Tom Mirga

The U.S. Senate could elevate Leonard Stark, the federal judge who has presided over AstraZeneca’s 340B contract pharmacy lawsuit, to a federal appeals court as soon as the end of this week.

Leonard Stark, the federal judge who presided over AstraZeneca’s 340B contract pharmacy lawsuit from its start last year, is on the verge of being elevated to a higher court, possibly by the end of this week. If that happens before

…

With Public Health Emergency Extended, 340B Flexibilities to Continue

In Federal, RegulatoryJanuary 19, 2022189 Views

Tom Mirga

340B program flexibilities will continue for another 90 days under the latest extension of the COVID-19 national public health emergency.

340B program flexibilities will continue under the eighth 90-day extension of the COVID-19 national public health emergency (PHE) late last week.

Please Login or Become a Paid Subscriber to View this Content

…

BMS Clamps Down on 340B Contract Pharmacy for Most of its Drugs but Expands 340B Access to its Controversial Myeloma Meds Program

In Breaking, Pharma IndustryJanuary 15, 20221607 Views

Tom Mirga

BMS yesterday imposed restrictions on 340B pricing on most of its covered outpatient drugs, while liberalizing its policy on access to 340B pricing on its expensive cancer drugs Revlimid, Pomalyst, and Thalomid.

Bristol Myers Squibb (BMS) yesterday became the 12^th drug manufacturer to impose restrictions on 340B pricing when hospitals and grantee covered entities contract with pharmacies to dispense drugs to patients.

Please Login or Become a Paid

…

News Alert: NACHC Long-Time Leader Van Coverden Takes Leave, Could Augur Generational Change

In Trade AssociationJanuary 14, 2022814 Views

Tom Mirga

NACHC informed health center stakeholders last night that its long-time leader Tom Van Coverden (left) has taken leave. NACHC Senior Vice President for Western Operations Rachel Gonzalez-Hanson has been appointed NACHC's interim president and CEO.

The National Association of Community Health Centers said in an email to its contacts yesterday that Tom Van Coverden, 74, hired by NACHC in 1975 and its leader for decades, has taken leave and been replaced by an interim president

…

340B-Related Conference Organizers Readjust as COVID-19 Persists

In Trade AssociationJanuary 13, 2022507 Views

Tom Mirga

The Marriott Marquis San Diego is the venue for both the 340B Coalition 2022 winter conference and the preceding 340B University educational program.

The 340B Coalition, citing the ongoing COVID-19 pandemic, decided Tuesday to give registrants for its upcoming Jan. 31 to Feb. 2 winter conference in San Diego, Calif., the option of attending in person or remotely via an online portal.

…